Amy Burd

Also affiliated with United Therapeutics (United States), University Cancer and Blood Center, Friends of Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates”.

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

Blood Advances(2022)10.1182/bloodadvances.2022008625

N/A

0.839DataRank · unranked

19 citations

Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock +35 more

A precision medicine classification for treatment of acute myeloid leukemia in older patients

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01110-5

N/A

0.719DataRank · unranked

15 citations

Jessica Kohlschmidt, Uma Borate, James S. Blachly, Shelley Orwick, Ann-Kathrin Eisfeld +15 more

Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial

Therapeutic Innovation & Regulatory Science(2021)10.1007/s43441-021-00277-w

N/A

0.353DataRank · unranked

5 citations

Hugh Levaux, Ross L. Levine, Amit Shah, James Denmark, Nyla Hereema +18 more

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0091

N/A

0.216DataRank · unranked

3 citations

Ronan Swords, Ying Huang, Shelley Orwick, Daelynn R. Buelow, Nicole Abbott +23 more

Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1661

N/A

0DataRank · unranked

19 citations

Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F. Madanat, Yuannyu Zhang +23 more